Hesperidin attenuates methotrexate-induced cardiotoxicity: Modulation of Nrf2 antioxidant defense and NF-κB/iNOS proinflammatory signaling.
Results indicate that hesperidin effectively attenuates MTX-induced cardiotoxicity and that HES may hold potential as a supplementary agent to minimize the cardiotoxic complications associated with MTX regimens, warranting further investigation.